Lannett Co Inc (LCI)
(Delayed Data from NYSE)
$8.54 USD
+0.70 (8.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.54 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[LCI]
Reports for Purchase
Showing records 21 - 40 ( 421 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
FY4Q20 Recap - Bottoming Out for Long- Term Growth
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
FY3Q20 Recap - Relatively Stable Given Current Environment
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
FY2Q20 Recap - Revenue Upside Offset by Margin Downside
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
FY3Q19 Recap - Continued Progress Heading into FY2020
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.